Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The management of multiple sclerosis in children: a European view

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Male factor infertility and risk of multiple sclerosis: A register-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clinical utility of anti-MOG antibody testing in a Danish cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Multi-dimensional microstructural imaging offers novel in-vivo insights into brain pathology: an application to multiple sclerosis

    Research output: Contribution to conferenceConference abstract for conferenceResearch

  4. HVAD ER BETYDNINGEN AF EN KORTIKAL LÆSION? – ET 7T STUDIE FOR PATIENTER MED MULTIPEL SKLEROSE

    Research output: Contribution to conferencePosterResearch

  • Angelo Ghezzi
  • Brenda Banwell
  • Alexey Boyko
  • Maria Pia Amato
  • Banu Anlar
  • Morten Blinkenberg
  • Maartje Boon
  • Massimo Filippi
  • Sergiusz Jozwiak
  • Immy Ketelslegers
  • Barbara Kornek
  • Ming Lim
  • Eva Lindstrom
  • Congor Nadj
  • Rinze Neuteboom
  • Maria A Rocca
  • Kevin Rostasy
  • Marc Tardieu
  • Evangeline Wassmer
  • Coriene Catsman-Berrevoets
  • Rogier Hintzen
View graph of relations
About 3-5% of all patients with multiple sclerosis experience the onset of their disease under the age of 16. A significant proportion of paediatric multiple sclerosis patients develop significant cognitive disturbances and persistent physical disability. The high relapse rate and the morbidity in the paediatric multiple sclerosis population has triggered the use of disease-modifying therapies that have been shown to reduce relapse rate, disease progression and cognitive decline in adult patients with multiple sclerosis. Hard evidence for the right treatment and its appropriate timing is scarce in paediatric multiple sclerosis. Nevertheless, expertise in this field has grown thanks to recent open-label trials and experience generated in specialized centres. In spring 2009, a first meeting was held in Rotterdam with clinicians from 11 European countries (one from Canada) that are all active in the management of paediatric multiple sclerosis. One of the aims was to generate a common view on the management of paediatric multiple sclerosis patients. The result of this meeting is presented here to help standardize treatment and to support clinicians with less experience in this field.
Original languageEnglish
JournalMultiple sclerosis (Houndmills, Basingstoke, England)
Volume16
Issue number10
Pages (from-to)1258-67
Number of pages10
DOIs
Publication statusPublished - 1 Oct 2010

ID: 32299256